Skip to content
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
← Tools
Tools · FilingsUpdated with new filings

Japan AGM Voting Results & Director Approval

Annual meeting voting results, director support and shareholder dissent.

Data through · Updated with new filings

0

board nominees with under 80% support at 2026 meetings

The lowest was Wakamoto Pharmaceutical's nominee at 85.71%.

Lowest director approval

1
Download CSVAll selected filings

1 meeting · 5 board nominees, each meeting's lowest approval first

The line marks 80% approval.

Lowest director approval
DirectorProposalApprovalResultFiling
五十嵐 新+4 other nominees, 85.75%–98.93%Wakamoto Pharmaceutical4512 · わかもと製薬Election of 4 directors (excluding audit committee directors)
Original (Japanese)取締役(監査等委員である取締役を除く。)4名選任の件
85.71%Votes cast: 86.04% · For 257,351 / Against 41,770 / Abstain 0ApprovedFiled  — filing S100YKND

Rejected proposals

1
Rejected proposals
CompanyProposalApprovalResultFiling
Wakamoto Pharmaceutical4512 · わかもと製薬Partial amendment of the articles of incorporation regarding formulation of a medium-term management plan for enhancing shareholder valueMachine translated
Original (Japanese)株主価値向上に向けた中期経営計画策定に関する定款一部変更の件
17.08%Votes cast: — · For 51,286 / Against 247,775 / Abstain —RejectedFiled  — filing S100YKND

Shareholder proposals ≥ 20%

0

No stored data for this selection.

Approval is the ratio the company states (usually of the voting rights of shareholders present); votes cast are for ÷ (for + against + abstain).

† Percentage of votes cast; company did not state a ratio.

† Company-stated ratio differs from tallied votes.

All tools →